MediWound (MDWD) Share-based Compensation (2014 - 2025)
MediWound (MDWD) recorded quarterly Share-based Compensation of -$662000.0 in Q4 2025, up 10.54% quarter-over-quarter from -$740000.0 in Q3 2025, and up 19.46% on a YoY basis from -$554138.5 in Q4 2024.
MediWound (MDWD) Share-based Compensation (2014 - 2025) Analysis & Trends
MediWound's Share-based Compensation history runs 12 years deep, the most recent figure standing at -$662000.0 for Q4 2025.
- In Q4 2025, Share-based Compensation rose 19.46% year-over-year to -$662000.0; the TTM figure through Dec 2025 stood at -$3.1 million (down 14.56% YoY), while the FY2025 annual figure was $3.1 million, up 199.04% from the prior year.
- Share-based Compensation was -$662000.0 for Q4 2025 at MediWound, up from -$740000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of -$298000.0 in Q4 2023 to a low of -$1.0 million in Q3 2024.
- Historically, Share-based Compensation has averaged -$602583.3 across 5 years, with a median of -$630500.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation surged 53.58% in 2023, then slumped 236.33% in 2024.
- A 5-year view of Share-based Compensation shows it stood at -$390000.0 in 2021, then sank by 64.62% to -$642000.0 in 2022, then surged by 53.58% to -$298000.0 in 2023, then sank by 175.84% to -$822000.0 in 2024, then grew by 19.46% to -$662000.0 in 2025.
- The last three Share-based Compensation figures came in at -$662000.0 (Q4 2025), -$740000.0 (Q3 2025), and -$844000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 26.47 Mn |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -662,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -662,000.00 |
| Dec 31, 2025 | -662,000.00 |
| Sep 30, 2025 | -740,000.00 |
| Sep 30, 2025 | -740,000.00 |
| Mar 31, 2025 | -844,000.00 |
| Mar 31, 2025 | -844,000.00 |
| Dec 31, 2024 | -822,000.00 |
| Dec 31, 2024 | -822,000.00 |
| Sep 30, 2024 | -1.05 Mn |
| Sep 30, 2024 | -1.05 Mn |
| Mar 31, 2024 | -512,000.00 |
| Mar 31, 2024 | -512,000.00 |
| Dec 31, 2023 | -298,000.00 |
| Dec 31, 2023 | -298,000.00 |
| Sep 30, 2023 | -311,000.00 |
| Sep 30, 2023 | -311,000.00 |
| Mar 31, 2023 | -619,000.00 |
| Mar 31, 2023 | -619,000.00 |
| Dec 31, 2022 | -642,000.00 |
| Dec 31, 2022 | -642,000.00 |